ArticleJournal of cheminformatics2026
Novel molecular design via a scaffold-aware transformer with multi-scale attention mechanisms.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Recent advancements in artificial intelligence have demonstrated enhanced potential in accelerating drug discovery by exploring vast chemical spaces and predicting molecular properties. In particular, scaffold-constrained molecular generation has enabled the incorporation of structural constraints into the generation process. However, effectively integrating multi-scale structural information with activity-guided optimization remains challenging. To overcome these limitations, we propose a novel framework that integrates a transformer-based generative model and a graph attention network-based predictive model. The generative model produces molecules with desired structural characteristics by explicitly incorporating scaffold information, while the predictive model estimates the biological activity of the generated molecules. A supervised fine-tuning framework iteratively refines the generator through multi-stage tournament selection with experience memory. This framework guides the generator toward scaffold-consistent, high-affinity candidates while exploring novel chemical variations around a user-specified scaffold. Experimental results demonstrated that the proposed scaffold-aware transformer achieves competitive validity, uniqueness, and novelty, effectively generating novel compounds with high predicted binding affinity for biological targets. Meanwhile, an attention-based analysis extracted atom-level importance scores, highlighting the substructures that contribute to the predicted binding affinity and providing interpretable insights into structure-activity relationships. This study provides a practical and interpretable tool for scaffold-conditioned molecular generation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.